sb 202190 has been researched along with Asthma in 3 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhury, BK | 1 |
| Wild, JS | 1 |
| Alam, R | 1 |
| Klinman, DM | 1 |
| Boldogh, I | 1 |
| Dharajiya, N | 1 |
| Mileski, WJ | 1 |
| Sur, S | 1 |
| Peng, Q | 1 |
| Matsuda, T | 1 |
| Hirst, SJ | 2 |
| Hallsworth, MP | 1 |
| Moir, LM | 1 |
| Lai, D | 1 |
3 other studies available for sb 202190 and Asthma
| Article | Year |
|---|---|
In vivo role of p38 mitogen-activated protein kinase in mediating the anti-inflammatory effects of CpG oligodeoxynucleotide in murine asthma.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Cells, Cultured; C | 2002 |
Signaling pathways regulating interleukin-13-stimulated chemokine release from airway smooth muscle.
Topics: Adult; Aged; Asthma; Bronchial Hyperreactivity; Butadienes; Cells, Cultured; Chemokine CCL11; Chemok | 2004 |
Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchi; Butadienes | 2001 |